COMMUNICATIONS
Ana Bornadiego et al.
Methyl 2-oxo-2-(4-oxo-4H-chromen-3-yl)acetate (5a): Re-
action time: 7 min; yield: 85%, obtained as a bright brown
solid; mp 131–1358C (lit.[13] 133–1358C); IR: n=3063, 2955,
[2] A. Urbain, A. Marston, L. S. Grilo, J. Bravo, O. Purev,
B. Purevsuren, D. Batsuren, M. Reist, P. A. Carrupt, K.
Hostettmann, J. Nat. Prod. 2008, 71, 895–897.
[3] a) H. Sun, F. Chen, X. Wang, Z. Liu, Q. Yang, X.
Zhang, J. Zhu, L. Qiang, Q. Guo, Q. You, Eur. J. Med.
Chem. 2012, 51, 110–123; b) J.-H. Yoo, K. Kang, E. H.
Jho, Y.-W. Chin, J. Kim, C. W. Nho, Food Chem. 2011,
129, 1559–1566; c) L. L. Saraiva, P. Fresco, E. Pinto,
E. L. Sousa, M. Pinto, J. GonÅalves, Bioorg. Med.
Chem. 2003, 11, 1215–1225.
1
1731, 1694, 1649 cmÀ1; H NMR (500 MHz, CDCl3): d=8.66
(s, 1H), 8.25 (d, J=7.9 Hz, 1H), 7.77 (t, J=8.5 Hz, 1H),
7.56 (d, J=8.4 Hz, 1H), 7.52 (t, J=7.5, 1H), 4.00 (s, 3H);
13C NMR (126 MHz, CDCl3): d=184.7 (C), 174.8 (C), 164.4
(C), 162.4 (CH), 156.3 (C), 135.2 (CH), 127.1 (CH) 126.5
(CH), 124.9 (C), 120.1 (C), 118.8 (CH), 53.2 (CH3); MS
(CI): m/z (%)=261 (M+29, 22), 234 (M+2, 85), 233 (M+
1, 98), 232 (M+, 99), 217 (69), 121 (22).
[4] K. Matsumoto, Y. Akao, K. Ohguchi, T. Ito, T. Tanaka,
M. Iinuma, Y. Nozawa, Bioorg. Med. Chem. 2005, 13,
6064–6069.
General Procedure for the Synthesis of 4-
Aminoxanthones
[5] a) Y. Liu, Z. Ke, J. Cui, W. H. Chen, L. Ma, B. Wang,
Bioorg. Med. Chem. 2008, 16, 7185–7192; b) C. Portela,
C. M. Afonso, M. M. Pinto, D. Lopes, F. Nogueira, V.
do Rosario, Chem. Biodiversity 2007, 4, 1508–1519.
[6] a) K. K. Ghosh, H. H. Ha, N. Y. Kang, Y. Chandran,
Y. T. Chang, Chem. Commun. 2011, 47, 7488–7490;
b) V. Giannouli, I. K. Kostakis, N. Pouli, P. Marakos, O.
Kousidou, G. N. Tzanakakis, N. K. Karamanos, J. Med.
Chem. 2007, 50, 1716–1719; c) I. K. Kostakis, N. Pouli,
P. Marakos, A. L. Skaltsounis, H. Pratsinis, D. Kletsas,
Bioorg. Med. Chem. 2006, 14, 2910–2934.
[7] Y. Liu, L. Huang, F. Xie, Y. Hu, J. Org. Chem. 2010, 75,
6304–6307.
[8] a) I. H. Bowen, J. R. Lewis, J. Chem. Soc. Perkin Trans.
1 1972, 683; b) A. A. Goldberg, H. A. Walker, J. Chem.
Soc. (Res) 1953, 1348.
To a solution of chromenone 5a–5e (0.3 mmol) in dry THF
(2 mL), isocyanide 6a–6g (0.36 mmol) and dienophile 3a–3d
(0.36 mmol) were successively added. The resulting mixture
was stirred at room temperature or 358C under a nitrogen
atmosphere until all the starting chromone had been con-
sumed, as judged by TLC. HCl (1N) was added to the reac-
tion mixture, the organic phase was extracted with CH2Cl2,
dried (Na2SO4) and concentrated. The resulting solid was fil-
tered and washed with hexane, giving the desired product
1a–1t.
Methyl
4-(cyclohexylamino)-1,3,10-trioxo-2-phenyl-
[2,3-f]isoindole-11-carboxylate
1,2,3,10-tetrahydrochromenoAHCNUTGTRENNUNG
(1a): Reaction temperature: 358C; reaction time: 96 h;
yield: 99%, obtained as a yellow solid; mp 250–2538C
(dec.); IR: n=3331, 2942, 2842, 1758, 1702, 1661 cmÀ1
;
1H NMR (500 MHz, CDCl3): d=8.31 (d, J=7.9 Hz, 1H),
7.82 (t, J=8.6 Hz, 1H) 7.51–7.34 (m, 9H), 6.95 (s, 1H), 4.44
(m, 1H), 4.11 (s, 3H), 2.17–1.15 (m, 10H); 13C NMR
(101 MHz, CDCl3): d=175.9 (C), 168.2 (C), 167.2 (C), 164.7
(C), 155.1 (C), 149.3 (C), 139.1 (C), 135.9 (CH), 131.4 (C),
129.3 (CH), 128.4 (CH), 127.2 (CH), 126.6 (CH), 125.8
(CH), 123.3 (C), 123.0 (C), 121.6 (C), 118.3 (C), 117.9 (CH),
112.2 (C), 54.5 (CH), 53.5 (CH3), 34.9 (CH2), 25.6 (CH2),
24.8 (CH2); MS (EI): m/z (%)=497 (M+,20), 496 (M, 62),
453 (92), 421 (35), 383 (52); HR-MS (EI): m/z=496.1626,
calcd. for C29H24N2O6: 496.1634.
[9] M. Pedro, F. Cerqueira, M. E. L. Sousa, M. S. J. Nasci-
mento, M. Pinto, Bioorg. Med. Chem. 2002, 10, 3725–
3730.
[10] a) A. Domling, W. Wang, K. Wang, Chem. Rev. 2012,
112, 3083–3135; b) E. Ruijter, R. Scheffelaar, R. V. A.
Orru, Angew. Chem. 2011, 123, 6358–6371; Angew.
Chem. Int. Ed. 2011, 50, 6234–6246; c) B. Ganem, Acc.
Chem. Res. 2009, 42, 463–472.
[11] a) A. G. Neo, J. Diaz, S. Marcaccini, C. F. Marcos, Org.
Biomol. Chem. 2012, 10, 3406–3416; b) S. Marcaccini,
A. G. Neo, C. F. Marcos, J. Org. Chem. 2009, 74, 6888–
6890; c) A. G. Neo, R. M. Carrillo, S. Barriga, E.
Moman, S. Marcaccini, C. F. Marcos, Synlett 2007, 327–
329.
Acknowledgements
[12] A. G. Neo, A. Bornadiego, J. Díaz, S. Marcaccini, C. F.
Marcos, Org. Biomol. Chem. 2013, 11, 6546–6555.
[13] S. Mkrtchyan, V. O. Iaroshenko, S. Dudkin, A. Ge-
vorgyan, M. Vilches-Herrera, G. Ghazaryan, D. M. Vo-
lochnyuk, D. Ostrovskyi, Z. Ahmed, A. Villinger, V. Y.
Sosnovskikh, P. Langer, Org. Biomol. Chem. 2010, 8,
5280–5284.
[14] K. Al-Zaydi, R. Borik, Molecules 2007, 12, 2061–2079.
[15] a) R. Fichtler, J.-M. Neudorfl, A. Jacobi von Wangelin,
Org. Biomol. Chem. 2011, 9, 7224–7236; b) P. Janvier,
H. Bienayme, J. P. Zhu, Angew. Chem. 2002, 114, 4467–
4470; Angew. Chem. Int. Ed. 2002, 41, 4291–4294; c) A.
Padwa, M. Dimitroff, A. G. Waterson, T. H. Wu, J. Org.
Chem. 1997, 62, 4088–4096.
We are thankful for financial support from Junta de Extrema-
dura and FEDER.
References
[1] a) K.-S. Masters, S. Bräse, Chem. Rev. 2012, 112, 3717–
3776; b) A. Detsi, D. Bouloumbasi, K. C. Prousis, M.
Koufaki, G. Athanasellis, G. Melagraki, A. Afantitis, O.
Igglessi-Markopoulou, C. Kontogiorgis, D. J. Hadjipav-
lou-Litina, J. Med. Chem. 2007, 50, 2450–2458;
c) M. M. M. Pinto, M. E. Sousa, M. S. J. Nascimento,
Curr. Med. Chem. 2005, 12, 2517–2538.
722
ꢀ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Adv. Synth. Catal. 2014, 356, 718 – 722